“DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY” (2026) International Research Journal of Pharmacy, 17(3), pp. 1–11. doi:10.56802/e8qzhp89.